Coronary Heart Disease Diagnostic Imaging Devices Market Analysis

Coronary Heart Disease Diagnostic Imaging Devices Market Analysis

To get key market trends

  Download Free Sample

Based on modality, the market is segmented into computed tomography (CT), x-ray, ultrasound, magnetic resonance imaging (MRI), and nuclear medicine. The computed tomography segment is forecasted to reach USD 443.8 million by 2032.
 

• CT scans offer high-resolution imaging that is crucial for visualizing the coronary arteries and detecting blockages or narrowing with major detail. This detailed and accurate information about a patient’s cardiac health condition enables doctors and healthcare professionals to provide appropriate treatment, leading to enhanced outcomes and thus propelling market growth.
   
• Additionally, technological advancements, such as the development of multi-slice CT scanners and dual-energy CT, are enhancing the capabilities of CT imaging, further propelling its adoption in clinical settings.
   

Based on application, the coronary heart disease diagnostic imaging devices market is bifurcated into arrhythmia, heart attack, heart failure, congenital heart conditions, and other applications. The heart attack segment accounted for USD 585.7 million in 2023.
 

• The increasing global incidence of heart attacks, driven by rising risk factors such as hypertension, obesity, diabetes, and unhealthy lifestyles, is significantly boosting the demand for advanced diagnostic imaging tools.
   
• Early and accurate detection of heart attacks is critical for effective treatment and patient outcomes, making medical imaging, indispensable in emergency and clinical settings.
   
• Additionally, growing awareness about the importance of early diagnosis and intervention is leading to more widespread use of imaging technologies in both preventive screening and post-heart attack monitoring.
   
• These factors, combined with increased healthcare spending and initiatives to reduce cardiovascular mortality rates, are expected to propel the heart attack segment's market growth substantially over the forecast period.
   

Based on end-use, the coronary heart disease diagnostic imaging devices market is bifurcated into hospitals, diagnostic imaging centers, ambulatory surgical centers (ASCs), and other end-users. The hospitals segment accounted for USD 742.1 million in 2023.
 

• Hospitals offer a wide range of services for cardiovascular diseases, including diagnostic imaging services, therapeutic interventions, emergency care, and long-term management. This results in a high volume of diagnostic imaging procedures and efficient treatment for patients, which eventually leads to widespread adoption and substantial market expansion.
   
• • Furthermore, hospitals are equipped with the latest and most advanced diagnostic imaging technologies, such as high-resolution CT scanners, MRI machines, and advanced ultrasound systems, driving higher trust and credibility and contributing to market growth.
   

The growth of the coronary heart disease diagnostic imaging devices market in the U.S. is projected to reach USD 1.3 billion by 2032.
 

• Coronary heart disease remains a leading cause of death in the U.S. According to the Centers for Disease Control and Prevention (CDC), heart disease accounts for one in every five deaths in the country. In 2021, roughly 695,000 Americans died from heart disease, with around 375,500 of these deaths attributed to coronary artery disease (CAD), the most common type of heart disease.
   
• The increasing incidence of coronary heart disease is influenced by factors such as aging, poor diet, lack of physical activity, and smoking. Thus, these factors drive the growing need for diagnostic imaging devices to detect and manage the condition at an early stage.
   

The coronary heart disease diagnostic imaging devices market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• Increased awareness about coronary heart disease and the importance of early diagnosis is leading to higher demand for diagnostic imaging. Public health campaigns and education programs are encouraging individuals to seek regular screenings in the country.
   
• Moreover, according to the British Heart Foundation, approximately 49,000 people under the age of 75 die from heart and circulatory diseases in the UK each year. Additionally, these diseases account for about 27% of all deaths in the country, totaling over 170,000 fatalities annually equivalent to roughly 480 deaths per day, or one every three minutes. This data underscores the increasing need for effective diagnostic methods and treatment options, thereby propelling the market growth in the country.
   

Japan coronary heart disease diagnostic imaging devices market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Japan, known for its advanced healthcare infrastructure and high standards of medical care, represents a significant market for coronary heart disease diagnostic imaging devices. The country invests heavily in research and development across multiple sectors, including healthcare technology. This substantial investment fosters innovation in diagnostic imaging devices, resulting in advanced solutions with enhanced functionality and effectiveness.
   

The coronary heart disease diagnostic imaging devices market in Saudi Arabia is expected to experience growth from 2024 to 2032.
 

• The expansion of hospitals and specialized cardiac centers in Saudi Arabia, along with the growth of private healthcare providers, is driving increased demand for advanced coronary heart disease diagnostic imaging devices.
   
• New healthcare facilities are being equipped with the latest imaging technologies to provide state-of-the-art care, while private hospitals and clinics are investing in these advanced tools to enhance their services and attract more patients.
   
• Thus, this combination of public and private sector investments is significantly contributing to the growth of the diagnostic imaging market in the country.